Cigna Corporation
NYSE:CI · New York Stock Exchange
-$4.44 today
Vol 2.44M · Avg 1.61M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
14.3%
avg 12.9%
ROIC
7.4%
avg 6.4%
ROA
3.8%
avg 3.5%
Analysis
ROE is currently the strongest return metric at 14.3% versus its period average of 12.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
David Michael Cordani | Chief Executive Officer & Chair of the Board | $5.44M | — | 61 | $0.00 | <0.01% |
Brian C. Evanko | President, COO & Director | $3.28M | — | 49 | $42,684.00 | 0.02% |
Nicole Susan Jones | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | $2.03M | — | 55 | $32,647.00 | 0.01% |
Ann Dennison | Executive Vice President & Chief Financial Officer | $1.88M | — | 55 | $0.00 | <0.01% |
Durga Prasad Koka | Executive Vice President & Global Chief Information Officer | $1.88M | — | — | $0.00 | <0.01% |
F. Everett Neville | Executive Vice President of Strategy & Business Development | $1.84M | — | 61 | $5,670.00 | <0.01% |
Jamie Kates | Senior VP & Tax and Global Chief Accounting Officer | — | — | 45 | $3,267.00 | <0.01% |
Melissa Skottegaard | Executive Vice President, Chief Marketing & Communications Officer | — | — | — | — | — |
Ralph Giacobbe | Senior Vice President of Investor Relations | — | — | — | — | — |
Andrea Nelson | EVP, General Counsel & Corporate Secretary | — | — | — | $0.00 | <0.01% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$999,916.21
Sells
18
$70.71M
Net Sentiment
$69.71M
Net selling
Most Active
Cordani David
14 transactions
1–10 of 19
Analysis
Insiders reported 1 buys worth $999,916.21 and 18 sells worth $70.71M over the last 12 months. That adds up to net selling of $69.71M. Cordani David was the most active insider with 14 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +12.7% | +12.3% (15yr)6 analysts |
| Revenue | N/A | N/A | +9.2% | +15.7% (15yr)5 analysts |
| Net Income | N/A | N/A | +8.9% | +12.5% (15yr)5 analysts |
| EBIT | N/A | N/A | +62.6% | +1.0% (15yr)5 analysts |
Analysis
Recent growth has been strongest in EBIT at +62.6% over three years. Forward estimates point to Revenue at +15.7% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
CVS Health Corporation
NYSE:CVS
$125.47B
Elevance Health Inc.
NYSE:ELV
$84.21B
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$62.07B
Cencora, Inc.
NYSE:COR
$52.61B
Becton, Dickinson and Company
NYSE:BDX
$52.17B
Cardinal Health, Inc.
NYSE:CAH
$51.95B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.04B
Humana Inc.
NYSE:HUM
$43.82B
Zoetis Inc.
NYSE:ZTS
$32.88B
Centene Corporation
NYSE:CNC
$30.36B
Who manages CI?
Cigna Corporation (CI) lists 10 active executives. The top listed executive is David Michael Cordani, Chief Executive Officer & Chair of the Board.
Are CI insiders buying or selling?
Recent insider activity shows net selling of $66.68M.
Explore More
Continue the stock analysis
Jump to another research area for this company.